In the developmental disorder tuberous sclerosis complex (TSC), patients carry mutations in either TSC1 or TSC2, leading to an increase in mTORC1 signaling and tumor formation throughout the body (Crino et al, 2006). The gene discussed is TSC2; the disease is neoplasm.